The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
Daily Express US on MSN1d
Millions missing out on key mineral that 'slashes Alzheimer's and Parkinson's risk'A nutritionist has said it's 'extremely worrying' that so many people are deficient in a mineral that can be easily obtained ...
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
10don MSN
A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...
Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds By India Edwards HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
The researchers added there were other ongoing trials examining if drugs like semaglutide, the active ingredient in Ozempic and Wegovy, may be able to help with Parkinson's. However, they noted ...
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...
GLP-1 drugs like Ozempic do not slow Parkinson's disease, study finds The trial showed no benefit in symptoms or brain scans Experts say more research is needed before using these drugs for brain ...
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit. A new study found that a drug in the same class ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback